Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 12:07 PM UTC
| NCT Number | NCT05317416 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 760 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | December 22, 2025 (Dec 22, 2025) |
As of March 2, 2026: Clinical trial NCT05317416 is currently active_not_recruiting participants. This clinical trial study for multiple myeloma is not currently accepting new participants at 30 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05317416 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05317416 was last updated Dec 22, 2025 (December 22, 2025). HelloStudys verifies this status automatically.